claim: potent neutralizing antibodies from covid-19 patients define multiple targets of therapies
evidence_1: ward, godelieve j. de bree, rogier w. sanders, marit j. van gils science 07 aug 2020 : 643-650 isolation of 403 monoclonal antibodies from covid-19 patients revealed convergent gene usage and multiple target epitopes.", "subsequent structural characterization of these potent nabs will guide vaccine design, and simultaneous targeting of multiple non-rbd and rbd epitopes with mab cocktails paves the way for safe and effective covid-19 prevention and treatment.", "indeed, therapeutic antibody cocktails with a variety of specificities have been used successfully against ebola virus disease ( 7) and are being tested widely in clinical trials for hiv-1 ( 31).", 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  "in addition to providing guidance for vaccine design, the antibodies described here are promising candidates for covid-19 treatment and prevention.")